Risk of bias in meta-analysis on erythropoietin-stimulating agents in heart failure Reply

被引：0
|
作者：
van der Meer, P. [1 ]
van Veldhuisen, D. J. [1 ]
机构：
[1] Univ Groningen, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands
来源：
HEART | 2009年 / 95卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1279 / 1279
页数：1
相关论文
共 50 条
  • [21] Erythropoietin treatment in patients with chronic heart failure: a meta-analysis
    van der Meer, P.
    Groenveld, H. F.
    Januzzi, J. L., Jr.
    van Veldhuisen, D. J.
    HEART, 2009, 95 (16) : 1309 - 1314
  • [22] Types of Erythropoietin-Stimulating Agents and Mortality among Patients Undergoing Hemodialysis
    Sakaguchi, Yusuke
    Hamano, Takayuki
    Wada, Atsushi
    Masakane, Ikuto
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2019, 30 (06): : 1037 - 1048
  • [23] The use of blood transfusions and erythropoietin-stimulating agents in Swedish palliative care
    Martinsson, Ulla
    Lundstrom, Staffan
    SUPPORTIVE CARE IN CANCER, 2009, 17 (02) : 199 - 203
  • [24] Correcting Anemia in Heart Failure: A Meta-Analysis of the Efficacy and Safety of Erythropoiesis-Stimulating Agents
    Lawler, Patrick R.
    Filion, Kristian B.
    Eisenberg, Mark J.
    CIRCULATION, 2009, 120 (18) : S735 - S735
  • [25] The use of blood transfusions and erythropoietin-stimulating agents in Swedish palliative care
    Ulla Martinsson
    Staffan Lundström
    Supportive Care in Cancer, 2009, 17 : 199 - 203
  • [26] "Ideal" parathyroid hormone in erythropoietin-stimulating agents-resistant anemia
    Ashraf, Bilal
    Bat, Taha
    Weinberg, Olga K.
    Moe, Orson W.
    Ibrahim, Ibrahim
    EJHAEM, 2022, 3 (01): : 159 - 162
  • [27] Meta-analysis: Risk of congestive heart failure (CHF) in selected targeted agents
    Escalante, Carmelita P.
    Elting, Linda S.
    Halm, Josiah
    Zalpour, Ali
    Bossi, Paolo
    Yusuf, SWamique
    Brito-Dellan, Norman
    Sahai, Sunil
    Bhadriraju, Satish
    Rouleau, Tanya
    Chang, Yuchia
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (29)
  • [28] The association of erythropoietin-stimulating agents and increased risk for AV-fistula dysfunction in hemodialysis patients. A retrospective analysis
    Anna Wärme
    Henrik Hadimeri
    Salmir Nasic
    Bernd Stegmayr
    BMC Nephrology, 22
  • [29] The association of erythropoietin-stimulating agents and increased risk for AV-fistula dysfunction in hemodialysis patients. A retrospective analysis
    Warme, Anna
    Hadimeri, Henrik
    Nasic, Salmir
    Stegmayr, Bernd
    BMC NEPHROLOGY, 2021, 22 (01)
  • [30] ANALYSIS OF RESPONSE TO ERYTHROPOIETIN-STIMULATING AGENTS (ESAs) IN PATIENTS WITH MYELODYSPLASTIC SYNDROME (MDS), EXPERIENCE OF A CENTER
    Jimenez, M.
    Molero, A.
    Saumell, S.
    Montoro, J.
    Merchan, B.
    Raheja, P.
    Varela, A.
    Perez, A.
    Gallur, L.
    Tazon, B.
    Ortega, M.
    Rodriguez, S.
    Bosch, F.
    Valcarcel, D.
    HAEMATOLOGICA, 2018, 103 : 183 - 183
12345